Posts
July 19 2012
Douglas S. Ellenoff, a member of the Firm, participated in “The Crowdfund Act – Framing the new regulatory landscape Symposium” sponsored in Washington by the Crowdfund Intermediary Regulatory Advocates (CFIRA). Mr. Ellenoff spoke on two different panels: The Mechanics of a Crowdfund Offering and Reaching the Crowd.
July 19 2012
Assured Pharmacy, Inc. announced the closing of their Private Placement offering in the amount of $300,000. EG&S acted as counsel to the Investor.
July 19 2012
IsoRay, Inc. announced the closing of their Registered Direct offering in the amount of $3,500,000. EG&S acted as counsel to the placement agent.
July 06 2012
MYOS Corporation announced the closing of their PIPE offering in the amount of $5,600,000. EG&S acted as counsel to MYOS Corporation.
July 02 2012
Ellenoff Grossman & Schole LLP was ranked #1 for placement agent representation in PIPE transactions (by number of transactions) for the first half of 2012.
June 22 2012
Mr. Douglas S. Ellenoff, a member of the Firm, participated in an invitation only JOBS Act Roundtable at New York University. Among the invitees were Josh Bonnie, partner at Simpson, Thacher & Bartlett; Tim Bowler, Deputy Assistant Secretary for Capital Markets, Treasury; Ryan Bubb, professor, NYU School of Law; Robert Buckholz, partner at Sullivan & Cromwell; Reggie Chambers, White House Fellow, White House National Economic Council; Eric Froman, Attorney-Advisor, Office of the Assistant General Counsel (Banking & Finance), Treasury; Don Graves, Deputy Assistant Secretary for Small Business, Community Development, and Affordable Housing Policy, Treasury; Katherine Harris, Policy Advisor, Office of Financial Institutions, Treasury; Joan Macleod Hemingway, Professor, University of Tennessee College of Law; Kevin Laws, Chief Operating Officer, AngelList; Barbara Novick, Vice Chairman, Blackrock; Douglas Rand, Senior Policy Advisor, White House Office of Science and Technology Policy; and Jeff Rubin, Partner at Hogan Lovells.
June 15 2012
iSIGN Media Solutions, Inc., a leading provider of interactive mobile advertising solutions that serves advertisers, manufacturers, retailers and advertising agencies throughout North America, announced that its shares will be trading on the OTCQX International, the premier tier of the U.S. over-the-counter market. EG&S will serve as iSIGN's Principal American Liaison ("PAL") on the OTCQX International, and will be responsible for providing guidance to iSIGN on OTCQX requirements and U.S. securities law.
June 13 2012
Novelos Therapeutics, Inc. announced the closing of their Registered Direct offering in the amount of $5,420,800. EG&S acted as counsel to the placement agent.